Volume with low cost is Biocon Biologics’ big plan

The Biocon subsidiary will chart a path that ensures high volumes and low costs, unlike competitors. The company plans to create an ecosystem where patients not only have access to the right medicine, but also gets the right care without always reaching a hospital.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2RarAwU
via IFTTT